API tools faq
paste
Advertisement
Guest User

US Patent List on Cannabis. Copy and share!

a guest
Oct 6th, 2012
140
0
Never
Add comment
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 22.01 KB | None | 0 0
raw download clone embed print report
  1. The Cannabis Re-Education Center » united states government » us patent and trademark office
  2. File
  3. Size
  4. Last Modified
  5. Folder?? - 20110228.041047
  6. !--FEATURED PATENTS/FEATURED PATENTS - 20110221.122304
  7. 2304669_1942_Isolation_of_cannabidiol/2304669 1942 Isolation of cannabidiol - 20110217.005017
  8. 2354492_1944_Marihuana_active_compound/2354492 1944 Marihuana active compound - 20110217.005419
  9. 2419934_1947_Optically_active_tetrahydrodibenzopyrans_having_marihuana_activity_and_process_for_making_same/2419934 1947 Optically active tetrahydrodibenzopyrans having marihuana activity and process for .. - 20110217.010128
  10. 2419935_1947_Marihuana_active_compounds/2419935 1947 Marihuana active compounds - 20110217.010934
  11. 2419936_1947_Preparation_of_compounds_with_marihuana_activity/2419936 1947 Preparation of compounds with marihuana activity - 20110217.011517
  12. 2509386_1950_Dibenzopyran_marihuana-like_compounds/2509386 1950 Dibenzopyran marihuana-like compounds - 20110217.012129
  13. 2509387_1950_Dibenzopyran_marihuana-like_compounds/2509387 1950 Dibenzopyran marihuana-like compounds - 20110217.012513
  14. 3668224_1972_Process_of_producing_6a,_10a-trans-6a,7,8,10a-tetrahydrodibenzo_(b,d)-pyrans/3668224 1972 Process of producing 6a, 10a-trans-6a,7,8,10a-tetrahydrodibenzo (b,d)-pyrans - 20110217.013244
  15. 3728360_1973_Ester_derivatives_of_tetrahydrocannabinol/3728360 1973 Ester derivatives of tetrahydrocannabinol - 20110217.013646
  16. 3734930_1973_Direct_synthesis_of_(-)-trans-delta-9-tetrahydrocannabinol_from_olivetol_and_(+)-trans-delta-2-carene_oxide/3734930 1973 Direct synthesis of (-)-trans-delta-9-tetrahydrocannabinol from olivetol and (+)-tr.. - 20110217.005434
  17. 4025516_1977_Process_for_the_preparation_of_(-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans/4025516 1977 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. - 20110217.022419
  18. 4116979_1978_Process_for_the_preparation_of_(-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans/4116979 1978 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. - 20110217.030800
  19. 4126694_1978_Composition_and_method_for_treating_glaucoma/4126694 1978 Composition and method for treating glaucoma - 20110217.031302
  20. 4126695_1978_Anti-glaucoma_composition_and_method/4126695 1978 Anti-glaucoma composition and method - 20110217.031624
  21. 4179517_1979_Novel_tetrahydrocannabinol_type_compounds/4179517 1979 Novel tetrahydrocannabinol type compounds - 20110217.032121
  22. 4189491_1980_Tetrahydrocannabinol_in_a_method_of_treating_glaucoma/4189491 1980 Tetrahydrocannabinol in a method of treating glaucoma - 20110217.032351
  23. 4195078_1980_Nabilone_granulation/4195078 1980 Nabilone granulation - 20110219.131638
  24. 4279824_1981_Method_and_apparatus_for_processing_herbaceous_plant_materials_including_the_plant_cannabis/4279824 1981 Method and apparatus for processing herbaceous plant materials including the plant .. - 20110221.005824
  25. 4315862_1982_Process_for_preparing_cannabichromene/4315862 1982 Process for preparing cannabichromene - 20110219.132528
  26. 4327028_1982_Composition_of_matter/4327028 1982 Composition of matter - 20110219.132854
  27. 4464378_1984_Method_of_administering_narcotic_antagonists_and_analgesics/4464378 1984 Method of administering narcotic antagonists and analgesics - 20110219.134318
  28. 4476140_1984_Composition_and_method_for_treatment_of_glaucoma/4476140 1984 Composition and method for treatment of glaucoma - 20110219.133925
  29. 4758597_1988_Carenadiol_and_derivatives/4758597 1988 Carenadiol and derivatives - 20110220.235422
  30. 4837228_1989_Antiinflammatory_and_antimicrobial_compounds_and_compositions/4837228 1989 Antiinflammatory and antimicrobial compounds and compositions - 20110219.135422
  31. 4847290_1989_Delta_1-thc-7-oic_acid_and_analgesic_and_anti-inflammatory_agents/4847290 1989 Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents - 20110219.140914
  32. 4876276_1989_(3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols/4876276 1989 (3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols - 20110219.141600
  33. 4933363_1990_Method_for_effecting_systemic_delivery_of_delta-9-tetrahydrocannabinol/4933363 1990 Method for effecting systemic delivery of delta-9-tetrahydrocannabinol - 20110219.144031
  34. 5227537_1993_Method_for_the_production_of_6,12-dihydro-6-hydroxy-cannabidiol_and_the_use_thereof_for_the_production_of_trans-delta-9-tetrahydrocannabinol/5227537 1993 Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof.. - 20110221.005135
  35. 5237057_1993_Tetrahydrocannabinol_derivatives_and_protein_and_polypeptide_tetrahydrocannabinol_derivative_conjugates_and_labels/5237057 1993 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. - 20110219.144538
  36. 5292899_1994_Synthesis_of_11-nor-delta-9-tetrahydrocannabinol-9-carboxylic_acid_glucuronide/5292899 1994 Synthesis of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid glucuronide - 20110219.145249
  37. 5302703_1994_Tetrahydrocannabinol_derivatives_and_protein_and_polypeptide_tetrahydrocannabinol_derivative_conjugates_and_labels/5302703 1994 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. - 20110219.145809
  38. 5338753_1994_(3r,4r)-delta-6-tetrahydrocannabinol-7-oic_acids_useful_as_antiinflammatory_agents_and_analgesics/5338753 1994 (3r,4r)-delta-6-tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents .. - 20110219.150617
  39. 5342971_1994_Process_for_the_preparation_of_dibenzo[b,d]pyrans/5342971 1994 Process for the preparation of dibenzo[b,d]pyrans - 20110219.150655
  40. 5389375_1995_Stable_suppository_formulations_effecting_bioavailability_of_delta-9-thc/5389375 1995 Stable suppository formulations effecting bioavailability of delta-9-thc - 20110219.151015
  41. 5440052_1995_Compositions_useful_as_a_cannabinoid_receptor_probe/5440052 1995 Compositions useful as a cannabinoid receptor probe - 20110219.151453
  42. 5508037_1996_Stable_suppository_formulations_effecting_bioavailability_of_delta-9-thc/5508037 1996 Stable suppository formulations effecting bioavailability of delta-9-thc - 20110219.151931
  43. 5532237_1996_Indole_derivatives_with_affinity_for_the_cannabinoid_receptor/5532237 1996 Indole derivatives with affinity for the cannabinoid receptor - 20110219.152606
  44. 5538993_1996_Certain_tetrahydrocannabinol-7-oic_acid_derivatives/5538993 1996 Certain tetrahydrocannabinol-7-oic acid derivatives - 20110219.152901
  45. 5596106_1997_Cannabinoid_receptor_antagonists/5596106 1997 Cannabinoid receptor antagonists - 20110219.153207
  46. 5605906_1997_Cannabinoid_receptor_agonists/5605906 1997 Cannabinoid receptor agonists - 20110219.153325
  47. 5605928_1997_Antiemetic_compositions/5605928 1997 Antiemetic compositions - 20110219.153523
  48. 5631297_1997_Anandamides_useful_for_the_treatment_of_intraocular_hypertension.../5631297 1997 Anandamides useful for the treatment of intraocular hypertension... - 20110219.160906
  49. 5635530_1997_(3s,4s)-delta-6-tetrahydrocannabinol-7-oic_acids_and_derivatives_thereof,_processors_for_their_preparation_and_pharmaceutical_compositions_containing_them/5635530 1997 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processor.. - 20110219.154139
  50. 5688825_1997_Anandamide_amidase_inhibitors_as_analgesic_agents/5688825 1997 Anandamide amidase inhibitors as analgesic agents - 20110219.161202
  51. 5716638_1998_Composition_for_applying_active_substances_to_or_through_the_skin/5716638 1998 Composition for applying active substances to or through the skin - 20110219.161548
  52. 5747524_1998_Cannabinoid_receptor_antagonists/5747524 1998 Cannabinoid receptor antagonists - 20110219.161846
  53. 5804592_1998_Method_for_improving_disturbed_behavior_and_elevating_mood_in_humans/5804592 1998 Method for improving disturbed behavior and elevating mood in humans - 20110219.162419
  54. 5847128_1998_Water_soluble_derivatives_of_cannabinoids/5847128 1998 Water soluble derivatives of cannabinoids - 20110219.162859
  55. 5872148_1999_Compositions_useful_as_a_cannabinoid_receptor_probe/5872148 1999 Compositions useful as a cannabinoid receptor probe - 20110219.163222
  56. 5874459_1999_Anandamide_amidase_inhibitors_as_analgesic_agents/5874459 1999 Anandamide amidase inhibitors as analgesic agents - 20110219.163805
  57. 5925768_1999_pyrazolecarboxamide_derivatives_having_cannabinoid_receptor_affinity/5925768 1999 pyrazolecarboxamide derivatives having cannabinoid receptor affinity - 20110219.164326
  58. 5932610_1999_Tumor_necrosis_factor_alpha_(tnf-alpha)_inhibiting_pharmaceuticals/5932610 1999 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110219.164744
  59. 5939429_1999_Cardiovascular_uses_of_cannabinoid_compounds/5939429 1999 Cardiovascular uses of cannabinoid compounds - 20110219.164958
  60. 5948777_1999_Cannabinoid_receptor_agonists/5948777 1999 Cannabinoid receptor agonists - 20110219.165232
  61. 5977180_1999_Anandamide_analog_compositions_and_method_of_treating_intraocular_hypertension_using_same/5977180 1999 Anandamide analog compositions and method of treating intraocular hypertension usin.. - 20110219.165507
  62. 5990170_1999_Therapeutic_use_of_mono_and_bicarboxylic_acid_amides_active_at_the_peripheral_cannabinoid_receptor/5990170 1999 Therapeutic use of mono and bicarboxylic acid amides active at the peripheral canna.. - 20110219.165901
  63. 6008383_1999_Method_of_preparing_delta-9-tetrahydrocannabinol_esters/6008383 1999 Method of preparing delta-9-tetrahydrocannabinol esters - 20110219.170127
  64. 6013648_2000_Cb2_receptor_agonist_compounds/6013648 2000 Cb2 receptor agonist compounds - 20110219.170359
  65. 6017919_2000_Compounds_and_pharmaceutical_use_thereof/6017919 2000 Compounds and pharmaceutical use thereof - 20110219.232239
  66. 6096740_2000_Dexanabinol_derivatives_and_their_use_as_neuroprotective_pharmaceutical_compositions/6096740 2000 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions - 20110219.232844
  67. 6100259_2000_Cannabinoid_receptor_modulators/6100259 2000 Cannabinoid receptor modulators - 20110219.233213
  68. 6113940_2000_Cannabinoid_patch_and_method_for_cannabis_transdermal_delivery/6113940 2000 Cannabinoid patch and method for cannabis transdermal delivery - 20110219.233850
  69. 6132762_2000_Transcutaneous_application_of_marijuana/6132762 2000 Transcutaneous application of marijuana - 20110219.234036
  70. 6162829_2000_(3r,4r)-delta-8-tetrahydrocannabinol-11-oic_acids_useful_as_antiinflammatory_agents_and_analgesics/6162829 2000 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. - 20110219.234311
  71. 6166066_2000_Cannabinoids_selective_for_the_cb2_receptor/6166066 2000 Cannabinoids selective for the cb2 receptor - 20110219.234631
  72. 6274635_2001_Alkylated_resorcinol_derivatives_for_the_treatment_of_immune_diseases/6274635 2001 Alkylated resorcinol derivatives for the treatment of immune diseases - 20110219.235354
  73. 6284788_2001_Use_of_known_agonists_of_the_central_cannabinoid_receptor_cb1/6284788 2001 Use of known agonists of the central cannabinoid receptor cb1 - 20110219.235654
  74. 6328992_2001_Cannabinoid_patch_and_method_for_cannabis_transdermal_delivery/6328992 2001 Cannabinoid patch and method for cannabis transdermal delivery - 20110220.000814
  75. 6331560_2001_Tumor_necrosis_factor_alpha_(tnf-alpha)_inhibiting_pharmaceuticals/6331560 2001 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110220.002503
  76. 6344474_2002_Use_of_central_cannabinoid_receptor_antagonists_for_regulating_appetence/6344474 2002 Use of central cannabinoid receptor antagonists for regulating appetence - 20110220.002717
  77. 6355650_2002_(3r,4r)-delta-8-tetrahydrocannabinol-11-oic_acids_useful_as_antiinflammatory_agents_and_analgesics/6355650 2002 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. - 20110220.002953
  78. 6380175_2002_Method_for_enhancement_of_delivery_of_thc_by_the_administration_of_its_prodrugs_via_the_nasal_route/6380175 2002 Method for enhancement of delivery of thc by the administration of its prodrugs via.. - 20110220.003309
  79. 6383513_2002_Compositions_comprising_cannabinoids/6383513 2002 Compositions comprising cannabinoids - 20110220.003536
  80. 6391909_2002_Anandamide_inhibitors_as_analgesic_agents/6391909 2002 Anandamide inhibitors as analgesic agents - 20110220.003752
  81. 6448288_2002_Cannabinoid_drugs/6448288 2002 Cannabinoid drugs - 20110220.004111
  82. 6509005_2003_delta-9_tetrahydrocannabinol_(delta-9_thc)_solution_metered_dose_inhaler/6509005 2003 delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhaler - 20110220.010440
  83. 6509367_2003_Pyrazole_cannabinoid_agonist_and_antagonists/6509367 2003 Pyrazole cannabinoid agonist and antagonists - 20110220.010824
  84. 6545041_2003_Tumor_necrosis_factor_alpha_(tnf-alpha)_inhibiting_pharmaceuticals/6545041 2003 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110220.011159
  85. 6563009_2003_Vasodilator_cannabinoid_analogs/6563009 2003 Vasodilator cannabinoid analogs - 20110220.011723
  86. 6566560_2003_Resorcinolic_compounds/6566560 2003 Resorcinolic compounds - 20110220.012340
  87. 6579900_2003_Anandamide_amidase_inhibitors_as_analgesic_agents/6579900 2003 Anandamide amidase inhibitors as analgesic agents - 20110220.013014
  88. 6610737_2003_Non_psychotropic_cannabinoids/6610737 2003 Non psychotropic cannabinoids - 20110220.013607
  89. 6630507_2003_Cannabinoids_as_antioxidants_and_neuroprotectants/6630507 2003 Cannabinoids as antioxidants and neuroprotectants - 20110217.040403
  90. 6642258_2003_Use_of_central_cannabinoid_receptor_antagonist_for_preparing_medicines/6642258 2003 Use of central cannabinoid receptor antagonist for preparing medicines - 20110220.141047
  91. 6653304_2003_Cannabinoid_receptor_modulators,_their_processes_of_preparation,_and_use_of_cannabinoid_receptor_modulators_for_treating_respiratory_and_non-respiratory_diseases/6653304 2003 Cannabinoid receptor modulators, their processes of preparation, and use of cannabi.. - 20110220.141700
  92. 6703418_2004_Appetite_stimulation_and_induction_of_weight_gain_in_patients_suffering_from_symptomatic_hiv_infection/6703418 2004 Appetite stimulation and induction of weight gain in patients suffering from sympto.. - 20110220.141926
  93. 6713048_2004_Delta-9_tetrahydrocannabinol_(delta-9_thc)_solution_metered_dose_inhalers_and_methods_of_use/6713048 2004 Delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhalers and metho.. - 20110220.142152
  94. 6747058_2004_Stable_composition_for_inhalation_therapy_comprising_delta-9-tetrahydrocannabinol_and_semiaqueous_solvent_therefor/6747058 2004 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol a.. - 20110220.142350
  95. 6825209_2004_Compounds_having_unique_cb1_receptor_binding_selectivity_and_methods_for_their_production_and_use/6825209 2004 Compounds having unique cb1 receptor binding selectivity and methods for their prod.. - 20110220.142627
  96. 6864291_2005_Agonists_specific_for_the_peripheral_cannabinoid_receptor/6864291 2005 Agonists specific for the peripheral cannabinoid receptor - 20110220.142827
  97. 6900236_2005_Cannabimimetic_indole_derivatives/6900236 2005 Cannabimimetic indole derivatives - 20110220.143112
  98. 6903137_2005_Agonists_specific_for_the_peripheral_cannabinoid_receptor/6903137 2005 Agonists specific for the peripheral cannabinoid receptor - 20110220.144738
  99. 6930122_2005_Use_of_central_cannabinoid_receptor_antagonist_for_preparing_medicines_designed_to_facilitate_smoking_cessation/6930122 2005 Use of central cannabinoid receptor antagonist for preparing medicines designed to .. - 20110220.225951
  100. 6939977_2005_Analgesic_and_immunomodulatory_cannabinoids/6939977 2005 Analgesic and immunomodulatory cannabinoids - 20110220.230157
  101. 6943266_2005_Bicyclic_cannabinoid_agonists_for_the_cannabinoid_receptor/6943266 2005 Bicyclic cannabinoid agonists for the cannabinoid receptor - 20110220.230355
  102. 6949582_2005_Method_of_relieving_analgesia_and_reducing_inflamation_using_a_cannabinoid_delivery_topical_liniment/6949582 2005 Method of relieving analgesia and reducing inflamation using a cannabinoid delivery.. - 20110220.230551
  103. 6974568_2005_Treatment_for_cough/6974568 2005 Treatment for cough - 20110220.231124
  104. 6995187_2006_Peripheral_cannabinoid_receptor_(cb2)_selective_ligands/6995187 2006 Peripheral cannabinoid receptor (cb2) selective ligands - 20110220.231316
  105. 7049329_2006_Amines_that_inhibit_a_mammalian_anandamide_transporter,_and_methods_of_use_thereof/7049329 2006 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof - 20110220.231649
  106. 7057076_2006_Bicyclic_and_tricyclic_cannabinoids/7057076 2006 Bicyclic and tricyclic cannabinoids - 20110220.231942
  107. 7067539_2006_Cannabinoid_receptor_ligands/7067539 2006 Cannabinoid receptor ligands - 20110220.232124
  108. 7071213_2006_Cannabinoid_receptor_ligands/7071213 2006 Cannabinoid receptor ligands - 20110220.232329
  109. 7088914_2006_Device,_method_and_resistive_element_for_vaporizing_a_medicament/7088914 2006 Device, method and resistive element for vaporizing a medicament - 20110220.232627
  110. 7105685_2006_Cannabinol_derivatives/7105685 2006 Cannabinol derivatives - 20110220.232801
  111. 7109245_2006_Vasoconstrictor_cannabinoid_analogs/7109245 2006 Vasoconstrictor cannabinoid analogs - 20110220.233007
  112. 7119108_2006_Pyrazole_derivatives_as_cannabinoid_receptor_antagonists/7119108 2006 Pyrazole derivatives as cannabinoid receptor antagonists - 20110220.233254
  113. 7129239_2006_Purine_compounds_and_uses_thereof/7129239 2006 Purine compounds and uses thereof - 20110220.233510
  114. 7141669_2006_Cannabiniod_receptor_ligands_and_uses_thereof/7141669 2006 Cannabiniod receptor ligands and uses thereof - 20110220.233811
  115. 7145012_2006_Cannabinoid_receptor_ligands_and_uses_thereof/7145012 2006 Cannabinoid receptor ligands and uses thereof - 20110220.234023
  116. 7161016_2007_Cannabimimetic_lipid_amides_as_useful_medications/7161016 2007 Cannabimimetic lipid amides as useful medications - 20110220.234200
  117. 7169942_2007_Cannabinoid_derivatives,_methods_of_making,_and_use_thereof/7169942 2007 Cannabinoid derivatives, methods of making, and use thereof - 20110220.234343
  118. 7173027_2007_Receptor_selective_cannabimimetic_aminoalkylindoles/7173027 2007 Receptor selective cannabimimetic aminoalkylindoles - 20110220.234621
  119. 7176210_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7176210 2007 Cannabinoid receptor ligands and uses thereof - 20110220.234841
  120. 7179800_2007_Cannabinoids/7179800 2007 Cannabinoids - 20110220.235606
  121. 7183313_2007_Keto_cannabinoids_with_therapeutic_indications/7183313 2007 Keto cannabinoids with therapeutic indications - 20110220.235821
  122. 7217732_2007_Cannabinoid_receptor_agonists/7217732 2007 Cannabinoid receptor agonists - 20110221.000020
  123. 7220743_2007_Heterocyclic_cb1_receptor_antagonists/7220743 2007 Heterocyclic cb1 receptor antagonists - 20110221.000208
  124. 7229999_2007_Pyridine-3-carboxamide_derivatives_as_cb1_inverse_agonists/7229999 2007 Pyridine-3-carboxamide derivatives as cb1 inverse agonists - 20110221.000408
  125. 7232823_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7232823 2007 Cannabinoid receptor ligands and uses thereof - 20110221.000602
  126. 7235584_2007_Non_psychotropic_cannabinoids/7235584 2007 Non psychotropic cannabinoids - 20110221.000739
  127. 7241799_2007_Cannabimimetic_indole_derivatives/7241799 2007 Cannabimimetic indole derivatives - 20110221.000920
  128. 7247628_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7247628 2007 Cannabinoid receptor ligands and uses thereof - 20110221.001058
  129. 7268133_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7268133 2007 Cannabinoid receptor ligands and uses thereof - 20110221.001308
  130. 7276516_2007_Cb1_antagonist_compounds/7276516 2007 Cb1 antagonist compounds - 20110221.002759
  131. 7276613_2007_Retro-anandamides,_high_affinity_and_stability_cannabinoid_receptor_ligands/7276613 2007 Retro-anandamides, high affinity and stability cannabinoid receptor ligands - 20110221.002935
  132. 7285683_2007_Bicyclic_and_tricyclic_cannabinoids/7285683 2007 Bicyclic and tricyclic cannabinoids - 20110221.003404
  133. 7285687_2007_Cannabinoids/7285687 2007 Cannabinoids - 20110221.003830
  134. 7294644_2007_Cb_1_receptor_inverse_agonists/7294644 2007 Cb 1 receptor inverse agonists - 20110221.004028
  135. 7321047_2008_Separation_of_tetrahydrocannabinols/7321047 2008 Separation of tetrahydrocannabinols - 20110221.004243
  136. 7323576_2008_Synthetic_route_to_dronabinol/7323576 2008 Synthetic route to dronabinol - 20110221.004441
  137. 7329651_2008_Cannabimimetic_ligands/7329651 2008 Cannabimimetic ligands - 20110221.004633
  138. 7329658_2008_Cannabinoid_receptor_ligands_and_uses_thereof/7329658 2008 Cannabinoid receptor ligands and uses thereof - 20110221.004825
  139. 7335688_2008_Bicyclic_cannabinoid_agonists_for_the_cannabinoid_receptor/7335688 2008 Bicyclic cannabinoid agonists for the cannabinoid receptor - 20110221.005006
  140. 7344736_2008_Extraction_of_pharmaceutically_active_components_from_plant_materials/7344736 2008 Extraction of pharmaceutically active components from plant materials - 20110221.005455
  141. 7354929_2008_Cannabinoid_receptor_ligands_and_uses_thereof/7354929 2008 Cannabinoid receptor ligands and uses thereof - 20110221.010029
  142. 7358245_2008_Treatment_of_gastroesophageal_reflux_disease/7358245 2008 Treatment of gastroesophageal reflux disease - 20110221.010322
  143. 7393842_2008_Pyrazole_analogs_acting_on_cannabinoid_receptors/7393842 2008 Pyrazole analogs acting on cannabinoid receptors - 20110221.010732
  144. 7399872_2008_Conversion_of_cbd_to_delta-8-thc_and_delta-9-thc/7399872 2008 Conversion of cbd to delta-8-thc and delta-9-thc - 20110221.011142
  145. 7402686_2008_Cannabinoid_crystalline_derivatives_and_process_of_cannabinoid_purification/7402686 2008 Cannabinoid crystalline derivatives and process of cannabinoid purification - 20110221.011644
  146. 7592328_2009_Natural_cyclodextrin_complexes/7592328 2009 Natural cyclodextrin complexes - 20110221.011900
  147. 7592468_2009_Production_of_delta-9_tetrahydrocannabinol/7592468 2009 Production of delta-9 tetrahydrocannabinol - 20110221.012444
  148. 7648696_2010_Composition_for_inhalation_comprising_delta-9-tetrahydrocannabinol_in_a_semiaqueous_solvent/7648696 2010 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous.. - 20110221.012955
  149. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 0KB 20110217.040441
  150. an_incomplete_list_of_cannabis-related_patents.txtan incomplete list of cannabis-related patents.txt 59KB 20110217.002348
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement
Public Pastes
Advertisement
We use cookies for various purposes including analytics. By continuing to use Pastebin, you agree to our use of cookies as described in the Cookies Policy.  OK, I Understand
Not a member of Pastebin yet?
Sign Up, it unlocks many cool features!